4 Stocks Trading Near 52-Week High With More Upside Potential
Investors target stocks that have lately been on a bull run. Stocks like PPC, THC, DVA and UHS are seeing price strength and have a high chance of carrying the momentum forward.
DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DaVita HealthCare (DVA) Is Up 0.56% in One Week: What You Should Know
Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is DaVita (DVA) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...
DaVita Inc. Announces Offering of $1.0 Billion Senior Notes
DENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $1.0 billion aggregate principal amount of its ...
DaVita HealthCare (DVA) Q2 Earnings and Revenues Surpass Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.08 per share a year ago.
2 Warren Buffett small-cap stocks to turn $100 into $1000 by 2025
As the second half of 2024 unfolds, the stock market continues to offer various investment opportunities ranging from large to small-cap equities.
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why
The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close.
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call
DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 6, 2024, at 5:00...
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts
DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close.
DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock?
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
US FTC probing DaVita, Fresenius Medical, Politico reports
The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita and Fresenius Medical Care over allegations that the companies have been illegally thwarting smaller competitors...
Here's Why You Should Add DaVita (DVA) to Your Portfolio
DaVita's (DVA) strength in its kidney care raises optimism about the stock.
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, DaVita HealthCare (DVA) closed at $142.16, marking a -0.53% move from the previous day.
Related Companies